Commentary
The body mass index (BMI) is commonly used as a proxy measure of body fatness. However, BMI does not reflect the level and distribution of body fat.
This article by A. Vilalta et al. (ProSciento, San Diego, CA, USA) provides a brief description of the most clinically relevant adipose tissue measurement techniques and discusses their value in obesity, diabetes, and NAFLD/NASH clinical research.
Previous Post
B cells aggravate NASH: an innate and adaptive signalling
Next Post
MAFLD biomarkers: a review